Study examples

pdficon32Komakhidze, T. et al (2015). Cost-effectiveness of pneumococcal conjugate vaccination in Georgia Vaccine, 29(31), 4963-72. doi: 10.1016/j.vaccine.2014.12.070. Download

Country-led ProVac analyses
pdficon32 Janusz, C. et al. (2015). Examining the cost of delivering routine immunization in Honduras. Vaccine, 33(Suppl 1), A53-9. doi: 10.1016/j.vaccine.2015.01.016. Download
pdficon32 Valdés, W. et al. (2015). Tracking financial flows for immunization in Honduras. Vaccine, 33(Suppl 1), A85-92. doi:10.1016/j.vaccine.2015.01.012. Download
pdficon32 Sigei, C. et al. (2015). Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine(Suppl1), A109-18. doi: 10.1016/j.vaccine.2014.12.079. Download
pdficon32 Peña Kieningera, M. et al. (2015). Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay. Vaccine, 33(Suppl 1), A143-53. doi: 10.1016/j.vaccine.2014.12.078. Download
pdficon32 Vizzotti, C. et al. (2015). Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina. Vaccine, 33(Suppl 1), A227-32. doi: 10.1016/j.vaccine.2014.12.077. Download
pdficon32 Ahmeti, A. et al. (2015). Cost-effectiveness of rotavirus vaccination in Albania. Vaccine, 33(Suppl 1), A201-8. doi:10.1016/j.vaccine.2014.12.075. Download
pdficon32 Urueña, A. et al. (2015). Cost-effectiveness analysis of rotavirus vaccination in Argentina. Vaccine, 33(Suppl 1), A126-34. doi: 10.1016/j.vaccine.2014.12.074. Download
pdficon32 Molina Aguilar, I.B. et al. (2015). Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras. Vaccine, 33(Suppl 1), A167-73. doi:10.1016/j.vaccine.2014.12.067. Download
pdficon32 Visekruna Vucina, V. et al. (2015). Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Vaccine, 33(Suppl 1), A209-A218. doi: 10.1016/j.vaccine.2014.12.043. Download
pdficon32 Walwyn, L. et al. Cost-effectiveness of HPV vaccination in Belize. Vaccine, 33(Suppl 1), A174-81. doi: 10.1016/j.vaccine.2014.12.042. Download
pdficon32 Javanbakht, M. et al. (2015). Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Vaccine, 33(Suppl 1), A192-200. doi: 10.1016/j.vaccine.2014.12.035. Download
pdficon32 Novaes, H.M. et al. (2015). Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine, 33(Suppl 1), A135-42. doi: 10.1016/j.vaccine.2014.12.031. Download
pdficon32 Mezones, E. et al. (2015). Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru. Vaccine, 33(Suppl 1), A154-66. doi: 10.1016/j.vaccine.2014.12.039. Download
pdficon32 Urueña, A. et al. (2011). Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina. Vaccine, 29(31), 4963-72. doi: 10.1016/j.vaccine.2011.04.111. Download

 

This post is also available in: French Spanish